Lab business > Regulations

Scientists said to be tweaking their experiments

23 March, 2015 by Lauren Davis

Australian researchers have stated that some scientists are unknowingly tweaking experiments and analysis methods in order to increase their chances of obtaining easily publishable results.


Australian IP system simplified

11 February, 2015

The Australian Government's Intellectual Property Laws Amendment Act 2015, which passed the Senate this week, introduces changes which are said to simplify aspects of Australia's intellectual property (IP) system.


Ethical guidelines on organ transplantation open for consultation

19 January, 2015

The National Health and Medical Research Council (NHMRC) has released a draft document to inform decisions around the allocation of organs for transplantation.


Ethical guidelines on organ transplantation open for consultation

19 January, 2015

The National Health and Medical Research Council (MHMRC) has released a draft document to inform decisions around the allocation of organs for transplantation.


No more ANZ therapeutic products regulator

21 November, 2014

The Australian and New Zealand governments have ceased efforts to establish a joint therapeutic products regulator, the Australia New Zealand Therapeutic Products Agency (ANZTPA).


TGA joins international collaboration to evaluate generic drugs

03 September, 2014

The Therapeutic Good Administration (TGA) has joined a pilot of the Decentralised Procedure (DCP) of the European Union - a collaboration on the evaluation of generic drug applications.


European cancer research could be at risk

31 July, 2014

The European Society For Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.


The debate on criminalising research fraud

18 July, 2014 by Lauren Davis

The BMJ has featured an article in which two experts go head to head discussing the potential criminalisation of research fraud.


Supreme Court decision upholds farmers' right to coexistence

30 May, 2014 by Lauren Davis

The Supreme Court of Western Australia has dismissed an organic farmer's claims for $85,000 in damages over contamination from his neighbour's genetically modified (GM) canola crop.


Qiagen products cleared by FDA

08 May, 2014

The US FDA has cleared the Qiagen artus C. difficile QS-RGQ MDx Kit to qualitatively detect Clostridium difficile, a widespread healthcare-associated infection. The test was developed in partnership with IntelligentMDx and CE marked in December 2013.


Public comment sought on ethical guidelines of assisted reproductive technology

14 March, 2014

The National Health and Medical Research Council's (NHMRC) Australian Health Ethics Committee (AHEC) is conducting a review of Part B (the clinical practice section) of the Ethical Guidelines on the Use of Assisted Reproductive Technology in Clinical Practice and Research, 2007.


Review to reduce red tape for universities

05 August, 2013

The Australian Government today released a major review examining how red tape can be reduced for universities while also supporting the quality and excellence of Australia’s world-class university system.


Vicam Global Mycotoxin Regulations Tool

15 July, 2013

Vicam, a Waters Corporation business, has introduced a single-source online tool that provides access to a comprehensive, simple-to-use database of global mycotoxin regulations. The Global Mycotoxin Regulations Tool, available as a web-based or mobile application, allows users to locate global mycotoxin limits by geography and commodity or food type in seconds.


US Supreme Court rules that human genes are not patentable

14 June, 2013

The United States Supreme Court has released its landmark decision in Association for Molecular Pathology et al v Myriad Genetics, Inc et al. The Court unanimously agreed that “A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patentable because it is not naturally occurring.”


Drug regulation or scientific censorship?

13 June, 2013

A group of leading scientists have claimed that the outlawing of psychoactive drugs amounts to the worst case of scientific censorship since the Catholic Church banned the works of Copernicus and Galileo.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd